Health Care: Drugs

Johnson & Johnson (JNJ: NYSE)

$105.88 1.16 | 1.11%
09/16/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 71.31B 67.22B 65.03B 61.59B
Cost of Sales 18.24B 17.99B 17.20B 15.85B
Gross Operating Profit 53.07B 49.23B 47.83B 45.73B
Selling, General, and Administrative Expenses 21.83B 20.87B 20.97B 19.42B
Research & Development 8.18B 7.66B 7.55B 6.84B
Operating Income before D & A (EBITDA) 23.06B 20.70B 19.31B 19.47B
Depreciation & Amortization 4.10B 3.67B 3.16B 2.94B
Interest Income 74.00M 64.00M 91.00M 107.00M
Other Income - Net -2.50B -1.63B -3.31B 768.00M
Special Income / Charges -1.16B -2.33B 0.00 0.00
Total Income Before Interest Expenses (EBIT) 15.95B 14.31B 12.93B 17.40B
Interest Expense 482.00M 532.00M 571.00M 455.00M
Pre-Tax Income 15.47B 13.78B 12.36B 16.95B
Income Taxes 1.64B 3.26B 2.69B 3.61B
Minority Interest 0.00 -339.00M 0.00 0.00
Net Income From Continuing Operations 13.83B 10.51B 9.67B 13.33B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 13.83B 10.51B 9.67B 13.33B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 13.83B 10.85B 9.67B 13.33B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
14.41B 11.68B 9.67B 13.33B
Preferred Dividends
Net Income Available To Common 13.83B 10.51B 9.67B 13.33B
Basic EPS from Continuing Ops. 4.92 3.94 3.54 4.85
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 4.92 3.94 3.54 4.85
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 4.92 3.94 3.54 4.85
Basic Normalized Net Income/Share 5.13 4.38 3.54 4.85
EPS fr Continuing Ops. 4.81 3.86 3.49 4.78
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 4.81 3.86 3.49 4.78
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 4.81 3.86 3.49 4.78
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
5.01 4.29 3.49 4.78
Dividends Paid per Share 2.59 2.40 2.25 2.11

Portfolios with JNJ

Latest JNJ Headlines from TheStreet

More Financial News for JNJ

Press Releases for JNJ

See All Press Releases

Partner Headlines for JNJ

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter